GH Axis

A synthetic growth-hormone-releasing hormone (GHRH) analogue studied in research into GHRH-receptor signalling, the GH axis and metabolic pathways in experimental models.

A synthetic analogue of the first 29 amino acids of growth-hormone-releasing hormone (GHRH 1–29), studied in research into GHRH-receptor signalling and the GH axis in experimental models.

A synthetic growth-hormone-releasing hexapeptide studied in research into ghrelin and GHS-receptor signalling within GH-axis models.

A selective pentapeptide growth-hormone secretagogue-receptor agonist studied in GH-axis signalling models.

2 mg lyophilised ipamorelin for smaller GH-axis laboratory protocols.

A 29-residue GHRH analogue (modified GRF 1-29) without Drug Affinity Complex, studied in GH-axis receptor models.

2 mg lyophilised CJC-1295 No DAC (modified GRF 1-29).

CJC-1295 with Drug Affinity Complex, a GHRH analogue studied in extended GH-axis signalling research.

A synthetic hexapeptide growth-hormone secretagogue studied at the ghrelin/GHS receptor in experimental models.

A hexapeptide GHS-receptor ligand studied in growth-hormone secretagogue research models.

2 mg lyophilised hexarelin reference peptide.

A recombinant analogue of insulin-like growth factor 1 with an N-terminal extension and Arg3 substitution, supplied as a research protein.

A pegylated analogue of mechano growth factor (IGF-1 Ec) studied in muscle-repair signalling models.

Mechano growth factor, a splice variant of IGF-1 studied in mechanical-load and repair pathway research.

A 344-residue follistatin isoform studied as an activin/myostatin-binding protein in laboratory models.

A synthetic GnRH analogue decapeptide for receptor-binding research. Not a licensed medicine.

A decapeptide gonadotropin-releasing hormone analogue for receptor and assay research. Not a fertility medicine.

10 mg Ipamorelin research vial.

10 mg CJC-1295 (No DAC) research vial.

2 mg CJC-1295 with DAC research vial.

10 mg CJC-1295 with DAC research vial.

5 mg GHRP-2 research vial.

5 mg Hexarelin research vial.

0.1 mg IGF-1 LR3 research vial.

5 mg PEG-MGF research vial.

5 mg MGF research vial.

2 mg Tesamorelin research vial.

5 mg Tesamorelin research vial.

2 mg Sermorelin research vial.

10 mg Sermorelin research vial.

5 mg GHRP-6 research vial.

10 mg Kisspeptin-10 research vial.

0.2 mg Follistatin 344 research vial.

5 mg Triptorelin research vial.

5 mg Gonadorelin research vial.

20 mg Tesamorelin (GHRH analogue) research vial. Not recombinant hGH.